RT Journal Article
SR Electronic
T1 SARS-CoV-2 triggered neutrophil extracellular traps (NETs) mediate COVID-19 pathology
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.08.20125823
DO 10.1101/2020.06.08.20125823
A1 Veras, Flavio
A1 Pontelli, Marjorie
A1 Silva, Camila
A1 Toller-Kawahisa, Juliana
A1 Lima, Mikhael de
A1 Nascimento, Daniele
A1 Schneider, Ayda
A1 Caetité, Diego
A1 Rosales, Roberta
A1 Colón, David
A1 Martins, Ronaldo
A1 Castro, Italo
A1 Almeida, Glaucia
A1 Lopes, Maria Isabel
A1 Benatti, Maíra
A1 Bonjorno, Letícia
A1 Giannini, Marcela
A1 Luppino-Assad, Rodrigo
A1 de Almeida, Sérgio
A1 Vilar, Fernando
A1 Santana, Rodrigo
A1 Bollela, Valdes
A1 Martins, Maria
A1 Miranda, Carlos
A1 Borges, Marcos
A1 Pazin-Filho, Antônio
A1 Cunha, Larissa
A1 Zamboni, Dario
A1 Dal-Pizzol, Felipe
A1 Leiria, Luiz
A1 Siyuan, Li
A1 Batah, Sabrina
A1 Fabro, Alexandre
A1 Mauad, Thais
A1 Dolhnikoff, Marisa
A1 Duarte-Neto, Amaro.
A1 Saldiva, Paulo
A1 Cunha, Thiago
A1 Alves-Filho, José
A1 Arruda, Eurico
A1 Louzada-Junior, Paulo
A1 de Oliveira, Renê
A1 Cunha, Fernando
YR 2020
UL http://medrxiv.org/content/early/2020/06/09/2020.06.08.20125823.abstract
AB Severe COVID-19 patients develop acute respiratory distress syndrome that may progress to respiratory failure. These patients also develop cytokine storm syndrome, and organ dysfunctions, which is a clinical picture that resembles sepsis. Considering that neutrophil extracellular traps (NETs) have been described as an important factors of tissue damage in sepsis, we investigated whether NETs would be produced in COVID-19 patients and participate in the lung tissue damage. A cohort of 32 hospitalized patients with a confirmed diagnosis of COVID-19 and respective healthy controls were enrolled. NETs concentration was assessed by MPO-DNA PicoGreen assay or by confocal immunofluorescence. The cytotoxic effect of SARS-CoV-2-induced NETs was analyzed in human epithelial lung cells (A549 cells). The concentration of NETs was augmented in plasma and tracheal aspirate from COVID-19 patients and their neutrophils spontaneously released higher levels of NETs. NETs were also found in the lung tissue specimens from autopsies of COVID-19 patients. Notably, viable SARS-CoV-2 can directly induce in vitro release of NETs by healthy neutrophils in a PAD-4-dependent manner. Finally, NETs released by SARS-CoV-2-activated neutrophils promote lung epithelial cell death in vitro. These results unravel a possible detrimental role of NETs in the pathophysiology of COVID-19. Therefore, the inhibition of NETs represent a potential therapeutic target for COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFAPESP grants (2013/08216-2, 2020/05601-6), CNPq and CAPES grants.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The procedures followed in the study were approved by the National Ethics Committee, Brazil (CONEP, CAAE: 30248420.9.0000.5440). Written informed consent was obtained from recruited patients.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data supporting the findings of this study are available within the article [and/or] its supplementary materials.